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The influence of microbiota in human health is well-known. Imbalances in microbiome
structure have been linked to several diseases. Modulation of microbiota composition
through probiotic therapy is an attempt to harness the beneficial effects of commensal
microbiota. Although, there is wide knowledge of the responses induced by gut
microbiota, the microbial factors that mediate these effects are not well-known. Gram-
negative bacteria release outer membrane vesicles (OMVs) as a secretion mechanism
of microbial factors, which have an important role in intercellular communication. Here,
we investigated whether OMVs from the probiotic Escherichia coli strain Nissle 1917
(EcN) or the commensal E. coli strain ECOR12 trigger immune responses in various
cellular models: (i) peripheral blood mononuclear cells (PBMCs) as a model of intestinal
barrier disruption, (ii) apical stimulation of Caco-2/PMBCs co-culture as a model of intact
intestinal mucosa, and (iii) colonic mucosa explants as an ex vivo model. Stimulations
with bacterial lysates were also performed. Whereas, both OMVs and lysates activated
expression and secretion of several cytokines and chemokines in PBMCs, only OMVs
induced basolateral secretion and mRNA upregulation of these mediators in the co-
culture model. We provide evidence that OMVs are internalized in polarized Caco-2
cells. The activated epithelial cells elicit a response in the underlying immunocompetent
cells. The OMVs effects were corroborated in the ex vivo model. This experimental
study shows that OMVs are an effective strategy used by beneficial gut bacteria to
communicate with and modulate host responses, activating signaling events through
the intestinal epithelial barrier.
Keywords: Nissle 1917, probiotics, gut microbes, membrane vesicles, microbiota-host crosstalk, intestinal
mucosa, Caco-2/PBMC co-culture
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INTRODUCTION
Intestinal microbiota has a great impact on human health. These
microbial populations provide crucial benefits to the host, such
as metabolic activities that promote energy harvest and nutrient
absorption from food, development of the host immune system,
and prevention of gut colonization and infection by pathogens
(O’Hara and Shanahan, 2006; Garrett et al., 2010; Krishnan et al.,
2015). Disturbances in microbiota composition can contribute to
the development of diverse pathologies (Belkaid and Hand, 2014).
Recent metagenomics studies have revealed certain microbial
profiles (dysbiosis) associated with inflammatory, metabolic or
infectious diseases (Le Chatelier et al., 2013; Robles-Alonso
and Guarner, 2013; Sears and Garrett, 2014). Manipulation of
gut microbiota through diet, probiotics and other approaches
is a promising therapeutic strategy to prevent or alleviate
disorders correlated with imbalances in the intestinal microbiota
(Shanahan, 2011; Foxx-Orenstein and Chey, 2012).
The intestinal ecosystem is characterized by dynamic and
reciprocal interactions between the microbiota, the epithelium
and the mucosal immune system. This process requires
elaborated regulatory mechanisms to ensure symbiosis and
prevent aberrant responses that lead to pathological states. The
epithelial layer is the first line of defense against pathogens and
is also the surface where the host interacts with the microbiota.
Epithelial cells have a critical role in sensing intestinal bacteria.
They are equipped with a great variety of receptors that can
recognize specific conserved molecular patterns in microbes
pattern-recognition receptors (PRRs), such as the membrane-
bound toll-like receptors (TLRs). TLRs mainly signal through the
adaptor protein MyD88 to activate master transcription factors
like NF-kappa B, thus triggering cytokine secretion and activation
of host defense mechanisms. Other signaling PRRs are the
cytosolic NOD-like receptors, which can modulate apoptosis and
inflammatory responses (Jacobs and Braun, 2014; Thaiss et al.,
2014; Caballero and Pamer, 2015). However, the gut microbiota
does not directly interact with the intestinal epithelium. Both cell
types are physically separated by the mucus layer. Commensal
microbiota resides in the outer mucus layer, whereas the inner
mucin layer is highly compacted and prevents bacteria from
accessing the epithelial cells (Johansson et al., 2008; Vaishnava
et al., 2011). In this scenario, a key issue is how the crosstalk
between microbiota and the host is established. Proteins or
factors secreted by microbiota have a relevant role in intestinal
communication as they can diffuse through the mucin layer and
come into contact with the intestinal mucosa cells.
All bacteria release extracellular vesicles as a means of
communication with the environment. The best characterized
are the outer membrane vesicles (OMVs) produced by Gram-
negative bacteria. These vesicles act as a bacterial secretion
pathway for selected proteins and other active compounds
in a protected environment. In addition, they allow cell–
cell communication, without direct intercellular contact
(Kulp and Kuehn, 2010; Kim et al., 2015). Many studies
conducted in the last decade with Gram-negative pathogens
showed that OMVs are internalized in the host cell and
contribute to virulence by delivering cytotoxic factors, as well
as mediators that interfere with the immune system (Ellis
and Kuehn, 2010; Chatterjee and Chaudhuri, 2013; Schertzer
and Whiteley, 2013). At present, microbiota vesicles are
seen as key players in signaling processes in the intestinal
mucosa (Kaparakis-Liaskos and Ferrero, 2015; Olsen and
Amano, 2015). However, studies in this field are still very
scarce and mainly focused on Bacteroides fragilis (Shen et al.,
2012; Stentz et al., 2015), a main Gram-negative group in
the gastrointestinal tract of mammals. OMVs from this
commensal promote immunomodulatory effects and prevent
experimental colitis in mice. These effects are mediated by the
capsular polysaccharide A (PSA) through TLR-2. However,
a transcriptomic analysis in dendritic cells stimulated with
B. fragilis 1PSA-OMVs revealed changes in gene expression
that are PSA-independent (Shen et al., 2012). Akkermansia
muciniphila OMVs are also able to protect the progression
of experimental-induced colitis in mice (Kang et al., 2013).
Regarding Gram-positive bacteria, studies performed with
Bifidobacterium bifidum LMG13195 showed that membrane
vesicles from this probiotic can activate the maturation of
dendritic cells, which trigger the regulatory T cells (Treg)
response (López et al., 2012).
Our group reported the first vesicular proteome of a probiotic
strain, namely Escherichia coli Nissle 1917 (EcN) (Aguilera et al.,
2014). This proteomic study identified 192 vesicular proteins
that have functions related to adhesion, immune modulation or
bacterial survival in host niches, thus indicating that probiotic-
derived OMVs contain proteins that can target these vesicles
to the host and mediate their beneficial effects on intestinal
function (Aguilera et al., 2014). EcN is a Gram-negative probiotic
used in the treatment of intestinal disorders, especially in the
maintenance of ulcerative colitis (Kruis et al., 2004; Chibbar and
Dieleman, 2015). The strain, which was originally isolated from
a soldier who survived a severe outbreak of diarrhea during
the First World War, is a good colonizer of the human gut
and positively affects gastrointestinal homeostasis and microbiota
balance. It is known that EcN modulates the expression of
antimicrobial peptides and the immune system function in the
gut by expressing bacterial factors that specifically interact with
host TLRs (Hafez et al., 2010).
The EcN-mediated effects have been evidenced from a great
variety of in vitro and in vivo experiments performed essentially
with live probiotic suspensions (Sturm et al., 2005; Schlee et al.,
2007; Ukena et al., 2007; Zyrek et al., 2007; Arribas et al.,
2009). The aim of this study was to define whether the immune
modulation effects promoted by EcN are mediated through
released OMVs. We extended the analysis to other commensal
E. coli strains without probiotic traits, such as ECOR12. We
analyzed the modulation of the cytokine/chemokine response
by epithelial and immune cells upon stimulation with OMVs
isolated from these strains in different in vitro and ex vivo
models. We provide evidence that OMVs are internalized in
polarized Caco-2 cells, and that these activated cells trigger
an immune response in the underlying immunocompetent
cells. Ex vivo experiments performed with colonic mucosa
explants confirmed the role of OMVs in microbiota-gut signaling
processes.
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MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The probiotic strain EcN (serotype O6:K5:H1) was provided
by Ardeypharm (GmbH, Herdecke, Germany). ECOR12 is a
commensal E. coli strain isolated from a healthy human stool
sample (Ochman and Selander, 1984). Bacterial cells were grown
at 37◦C in Luria-Bertani broth (LB). Growth was monitored by
measuring the optical density at 600 nm.
Preparation of Bacterial Cell Lysates and
OMVs
Bacterial lysates were prepared from cells grown in LB medium.
Bacteria were collected by centrifugation (5,000 × g, 10 min,
4◦C) and resuspended in phosphate buffer saline (PBS) for sonic
disruption on ice. Cell debris was removed by centrifugation at
16,000× g for 30 min at 4◦C and the supernatant filtered through
a 0.22 µm-pore-size filter to remove any residual cell.
Outer membrane vesicles were isolated from culture
supernatants as described previously (Aguilera et al., 2014).
In brief, bacterial cells grown overnight in LB were pelleted
by centrifugation (10,000 × g, 20 min, 4◦C); the supernatants
were filtered through a 0.22 µm-pore-size filter (Millipore),
concentrated by centrifugation in a Centricon Plus-70 filter
device (Millipore) followed by an additional filtration step.
Vesicles were then collected by centrifugation at 150,000 × g for
1 h at 4◦C, washed and resuspended in PBS. Isolated OMVs were
examined by transmission electron microscopy after negative
staining as described previously (Egea et al., 2007).
Samples, either lysates or OMVs, were stored at −20◦C until
use. Sterility of samples was assessed on LB plates. Protein
concentration was determined by the method of Lowry et al.
(1951).
Immunoblotting of Lipopolysaccharide
(LPS)
Protein samples (bacterial lysates and OMVs) were separated on
15% SDS-PAGE and transferred to a Hybond-P polyvinylidene
difluoride membrane by using a Bio-Rad MiniTransblot
apparatus. The membrane was blocked in PBS-0.05% Tween-
20 and 5% skimmed milk (blocking solution) for 1 h at
room temperature, and then incubated with specific antibodies
against LPS (Abcam; 1:5,000 dilution in blocking solution)
for 16 h at 4◦C. The secondary antibody was donkey anti-
rabbit immunoglobulin horseradish peroxidase-linked, diluted
1:15,000 in blocking solution. The protein-antibody complex was
visualized by using the ECL Plus Western blotting detection
system (Amersham Pharmacia Biotech).
Cell Lines and Growth Conditions
Caco-2 human colon adenocarcinoma cells (ATCC HTB-37)
were obtained from the American Type Culture Collection. Cells
(passages 55–65) were routinely grown at 37◦C in a 5% CO2
atmosphere in Dulbecco’s modified eagle medium (DMEM) High
Glucose containing 25 mM HEPES, 1% non-essential amino
acids, 10% heat inactivated fetal calf serum (FCS) (Gibco BRL),
penicillin G (100 U/ml) and streptomycin (100 µg/ml; Gibco
BRL).
For Transwell cultures, 5 × 105 Caco-2 cells were seeded on
the apical compartment of 12 mm polycarbonate inserts (0.4 µm,
Transwell Corning) and experiments were performed when
confluent monolayers were fully polarized (18–20 days post-
confluence). During growth and differentiation the medium was
changed every 2 days in both compartments. Monolayer integrity
was controlled by measurement of the transepithelial electrical
resistance with a Millicell-ERS-2 volt-ohmmeter (Millipore,
Madrid, Spain) and by visual assessment of cell layer integrity
under the microscope. Prior to apical stimulation with OMVs
or bacterial lysates, the medium was changed to DMEM High
Glucose containing 25 mM HEPES, 1% non-essential amino
acids, 1% heat inactivated FCS and gentamycin (150 µg/ml). For
co-culture experiments, human peripheral blood mononuclear
cells (PBMCs) were added to the basolateral compartment at a
cell density of 2× 106 cells/ml.
PBMCs Isolation
Peripheral blood mononuclear cells were isolated from fresh
buffy coats of six healthy donors, provided by the “Banc de
Sang i Teixits” of Barcelona according to the signed agreement
with the Institution. Briefly, the buffy coat was centrifuged
over a Hystopaque density gradient (Hystopaque-1077, Sigma
Aldrich) following the manufacturer’s instructions. PBMCs
were suspended in DMEM High Glucose containing 25 mM
HEPES, non-essential amino acids, 1% heat inactivated FCS
and gentamycin (150 µg/ml) and adjusted to 2 × 106 cells/ml.
Stimulation with OMVs or bacterial lysates was performed in
24 well plates (PBMCs only) or in 12 mm Transwell inserts
(Caco-2/PBMCs co-culture).
Organ Culture of Human Colonic Mucosa
Macroscopically normal colonic tissue was obtained after
adenocarcinoma surgery from six patients undergoing right
colon resection. Full-thickness colonic wall specimens distant
from the tumor and without macroscopic lesions were rinsed
under a saline jet and washed twice in sterile saline at 4◦C.
Mucosal samples weighing 25–35 mg each were separated from
underlying tissue and placed with the epithelial surface facing
up on culture filter plates (15-mm diameter wells with 500-
µm bottom mesh, Netwell culture systems, Costar). Filters were
suspended over wells containing 1.5 ml of medium RPMI 1640
(Life Technologies) supplemented with 2 mM glutamine and
150 µg/ml gentamicin. Tissues were incubated during 5 h at
37◦C in humidified atmosphere and stimulated by the addition
of OMVs or bacterial lysates, as described below. During this
time oxygen supply was provided to preserve tissue integrity (95%
O2/5% CO2). Tissue viability was assessed by measuring lactate
dehydrogenase as described elsewhere (Borruel et al., 2003).
Stimulation Conditions
To investigate the interaction between OMVs and cells of the
intestinal mucosa, three different experimental approaches were
performed: (i) direct stimulation of PBMCs (2× 106 cells/ml), (ii)
apical stimulation of differentiated Caco-2/PBMCs co-cultures
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and (iii) apical stimulation of colonic mucosa explants. Each
experiment was conducted six times (six individual donors in
duplicate). Stimulations were performed with OMVs (50 µg/ml)
or bacterial lysates (100 ng/ml) from EcN or ECOR12 strains. The
concentration of these bacterial samples was selected according
to experimental procedures reported elsewhere (Schaar et al.,
2011; Güttsches et al., 2012). Cells were incubated at 37◦C
in a 5% CO2 atmosphere for 5 h (for expression analysis by
RT-qPCR) or 24 h (for quantification of secreted cytokines).
Incubation in growth medium was performed in parallel as a
control. For RNA isolation the medium was removed and cells
or tissue explants were suspended in appropriate volume of
RNA later R© (Ambion) to preserve RNA integrity and kept at
−80◦C until RNA extraction. For cytokine quantification, culture
supernatants were collected from direct stimulated PBMCs or
from the basolateral compartment in co-culture experiments.
Supernatants were clarified by centrifugation (300 × g, 5 min)
and stored in aliquots at −80◦C until use. In the ex vivo
experiments, both culture supernatant and tissue explants were
collected and processed after 5 h stimulation.
Cytokine and Chemokine Quantification
in Culture Supernatants
Secreted IL-10, TNF-α, and MIP1α were measured using a
cytometric bead array system (CBA FlexSet, BD Biosciences)
according to manufacturer’s instructions and analyzed by flow
cytometry (Gallios Beckman Coulter) in the Scientific and
Technological Services of the University of Barcelona (CCiT –
UB). Measurement of IL-8 and IL-6 was performed using ELISA
sets (BD Biosciences). IL-22 was quantified by ELISA using the
R&D System Duo Set.
RNA Isolation and Quantitative Reverse
Transcription PCR (RT-qPCR)
Total RNA was extracted from PBMCs and Caco-2 cells by
using the Illustra RNAspin Mini kit (GE Healthcare) according
to the manufacturer’s instructions. RNeasy Mini kit (Qiagen)
was used to extract total RNA from colonic tissue samples.
The concentration and purity of RNA samples were assessed by
the ratio of absorbance at 260 and 280 nm in a NanoDrop R©
spectrophotometer. RNA integrity was verified by visualization
of 28S and 18S rRNAs after 1% agarose/formaldehyde gel
electrophoresis.
RNA (1 µg for colon explants or 350 ng for PBMCs and
Caco-2 cells) was reverse transcribed using the High Capacity
cDNA Reverse Transcription kit (Applied Biosystems) in a final
volume of 20 µl following manufacturer’s recommendations. RT-
qPCR reactions were performed in a StepOne Plus PCR cycler
(Applied Biosystems) by using the Taqman Gene Expression
Master Mix, and the Taqman probes and primers for human IL-
10, MIP1α, TNF-α, IL-6, IL-8, IL-12, IL-22, TGF-β, β-defensin-
2 (hBD-2), β-defensin-1 (hBD-1) and mucin-1 (MUC1). The
standard PCR program used was: one denaturation cycle for
10 min at 95◦C followed by 40 cycles of 15 s at 95◦C and 1 min
at 60◦C. A control reaction was performed in the absence of
RNA. The housekeeping gene β-actin was used as a normalizing
gene. Relative gene expression was calculated as fold-change
compared with control and calculated by means of 11Ct
formula.
OMVs Labeling and Internalization Assay
To monitor OMVs internalization in intestinal epithelial cells,
vesicles were fluorescently labeled with rhodamine isothiocyanate
B-R18 (Molecular Probes) as described elsewhere (Bomberger
et al., 2009). OMVs purified as described above were washed
with PBS, resuspended in labeling buffer (50 mM Na2CO3,
100 mM NaCl, pH 9.2) in the presence of 1 mg/ml rhodamine
isothiocyanate B-R18 and incubated for 1 h at 25◦C. Labeled
OMVs were pelleted by centrifugation at 100,000 × g for 1 h
at 4◦C, resuspended in PBS (0.2 M NaCl) and washed twice
to fully remove the unbound dye. After a final centrifugation
step, the rhodamine labeled-OMVs were resuspended in PBS
(0.2 M NaCl) containing a protease inhibitor cocktail (Complete
Protease Inhibitor Tablet, Roche) and stored at 4◦C for up to
6 weeks.
OMVs internalization assays were performed using polarized
Caco-2 cells (18–20 days post-confluence) grown in 96-well plate
(Corning Incorporated, Costar R©). Prior to the assay, the medium
was replaced with rhodamine B-R18-labeled OMVs (2 µg/well)
suspended in DMEM medium in the absence of phenol red
and FCS. Cells were incubated at 37◦C and fluorescence was
measured over time using a ModulusTM Microplate fluorescence
(Turner BioSystems; Ex 570 nm; Em 595 nm). Fluorescence
intensity was normalized for fluorescence detected by labeled-
OMVs in the absence of epithelial cells.
OMVs internalization was assessed by confocal fluorescence
microscopy. Caco-2 cells were grown in 8-well chamber slider
(ibidi) and incubated with rhodamine B-R18-labeled OMVs
(2 µg) at 37◦C for 1 h, and then washed with PBS. Cells
were fixed with 3% paraformaldehyde, permeabilized with 0.05%
saponin (Sigma Aldrich) and blocked using PBS containing
1% bovine serum albumin. Nuclei were labeled with DAPI.
To visualize cell boundaries, the peripheral zonula occludens
ZO-1 protein was stained using anti-ZO-1 rabbit IgG antibody
(Invitrogen) and Alexa Fluor 488-conjugated goat anti-rabbit IgG
(Invitrogen). Confocal microscopy was carried out using a Leica
TCS SP5 laser scanning confocal spectral microscope with 63x
oil immersion objective lens. Images were captured with a Nikon
color camera (16 bit). Fluorescence was recorded at 405 nm
(blue; DAPI), 488 nm (green; Alexa Fluor 488), and 546 nm
(red; rhodamine isothiocynate B-R18). Z-stack images were taken
at 0.5 µm. Images were analyzed using Fiji image processing
package.
Statistical Analysis
Statistical analysis was performed using SPSS version 20.0
software (SPSS, Inc.) and data were expressed as mean ± SEM
(n = 6). To establish the distribution of the data, the test
Kolmogorov–Smirnov was run. To assess the effect of every
experimental condition compared to the other conditions, the
t-test (normal distribution) or the Mann–Whitney U-test (non-
normal distribution) were performed. Differences between more
than two groups were assessed using one-way ANOVA followed
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by Tukey’s test. Significant differences were established at
p ≤ 0.05.
Ethical Approval
All the procedures involving human patients were approved
by the local ethics committees (Comité Ético de Investigación
Clínica, Hospital Vall d’Hebron and Comité Ético del Banc de
Sang i Teixits de Barcelona). Written informed consent was
obtained from all patients (CEIC: PR(AG)56/2010).
RESULTS
Comparative Protein Profile and LPS
Analysis of OMVs Isolated from the
Probiotic EcN and the Commensal
ECOR12 Strains
Outer membrane vesicles from EcN and ECOR12 were
isolated from culture supernatants. Examination of OMVs by
transmission electron microscopy revealed that both strains
release vesicles ranging from 20 to 60 nm in diameter
(Figure 1A). To further compare the OMVs isolated from these
strains, their protein profile was analyzed by SDS-PAGE and the
LPS content was estimated by immunoblotting. Results showed
similar protein profiles and LPS amount in both strain vesicles
(Figures 1B,C). Immunoblotting of the LPS was also carried out
in EcN and ECOR12 lysates (Figure 1C).
OMVs from EcN and ECOR12 Induce
Cytokine Secretion in PBMCs
Human PBMCs, which include several types of immunogenic
cells, were used to evaluate the immunomodulatory effects of
OMVs secreted by EcN and ECOR12 strains. Direct stimulation
of these immune cells can be used as an in vitro model of
intestinal inflammation and barrier disruption.
PMBCs were stimulated by the addition of OMVs for 24 h in
the presence of gentamicin. Stimulations with bacterial lysates
were conducted in parallel for comparison. As illustrated in
Figure 2A, OMVs and lysates from both strains induced the
secretion of IL-10, MIP1α, TNF-α, IL-6, and IL-8 by PBMCs
(p ≤ 0.05). Secretion levels of MIP1α, IL-6, and IL-8 were in
the ng range. Lysates triggered greater activation than OMVs
in this cell model for all the cytokines and chemokines studied.
ECOR12 lysates tended to promote increased secretion levels of
proinflammatory cytokines than EcN lysates, although only the
results for TNF-α were statistically significant (Figure 2A).
Expression of these inflammatory and immunomodulatory
mediators was also analyzed by RT-qPCR after 5 h-stimulation.
The results confirmed that all genes were upregulated in
stimulated versus control cells (Figure 2B). Although, the
changes in gene expression triggered by OMVs or lysates did
not exactly match the secretion pattern of the soluble mediators
released (Figure 2A), the tendency of ECOR12 lysates to produce
greater cytokine activation was also apparent.
OMVs from EcN and ECOR12 Activate
Cytokine Production by PBMCs in
Co-culture with Caco-2 Cells
To evaluate the crosstalk between OMVs, intestinal epithelial
cells and immune cells, we used the Caco-2/PBMCs co-culture
Transwell model that simulates the interaction of microbiota with
the intestinal mucosa (Haller et al., 2000; Fang et al., 2010; Pozo-
Rubio et al., 2011). In this model, signaling between epithelial and
immune cells occurs through the release of soluble mediators.
Differentiated Caco-2 cells in the apical compartment were
challenged with OMVs from EcN or ECOR12, and with bacterial
lysates for comparison. After 24 h incubation, the level of
released cytokines was measured in the basolateral compartment.
Transepithelial electrical resistance was monitored before and
after each experiment to ensure the intact barrier function of
the monolayer. The results presented in Figure 3A show that
apical stimulation with OMVs elicited increased secretion of IL-
10, MIP1α, TNF-α, IL-6 and IL-8, whereas lysates from the same
strains did not produce any activation effect, yielding comparable
secreted levels as untreated control cells. Stimulations of Caco-
2 monolayers without underlying PBMCs were performed
in parallel. Analysis of cytokine secretion in the basolateral
compartment showed that polarized Caco-2 cells are almost
unresponsive in the absence of crosstalk with immune cells (data
not shown). This finding is in accordance with results reported
by other groups (Zoumpopoulou et al., 2009; Fang et al., 2010;
Pozo-Rubio et al., 2011).
In Caco-2/PBMCs co-cultures the cytokine secretion profile
was clearly different from that of PBMCs directly exposed
to bacterial samples. As the Caco-2 monolayer constitutes a
physical barrier to the bacterial factors, these results showed that
OMVs, but not lysates, could stimulate epithelial cells, which
in turn may signal to the underlying PBMCs. In this co-culture
model, activation of Caco-2 cells by OMVs was corroborated
by RT-qPCR analysis of the expression profile of IL-10, MIP1α,
TNF-α, IL-6 and IL-8 after 5 h stimulation. OMVs promoted
upregulation of all these mediators in Caco-2 cells in the apical
compartment (Figure 3B). Interestingly, the comparison of data
from stimulations performed with vesicles isolated from both
strains revealed that OMVs from the probiotic strain EcN
promoted a significantly higher increase in the expression of the
anti-inflammatory cytokine IL-10 (Figure 3B).
Gene expression analysis in PBMCs collected from the
basolateral compartment also revealed higher mRNA levels of
these mediators than in PBMCs collected from untreated co-
cultures (Figure 3C). However, due to variability in the data,
the results did not reach statistical significance. In this case, the
relative increased gene expression values were lower than those of
PBMCs directly stimulated by OMVs. These results are consistent
with the stimulation of PBMCs by soluble factors released from
epithelial cells upon exposure to OMVs.
In this co-culture system, the different cellular responses
to OMVs or to bacterial lysates may be attributed to specific
OMV-mediated communication and signaling mechanisms in
the epithelial barrier. Thus, we sought to prove that OMVs from
these E. coli strains are internalized in differentiated Caco-2 cells.
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FIGURE 1 | Analysis of EcN and ECOR12 OMVs. (A) Negative staining electron microscopy of isolated vesicles. OMVs are indicated by arrowheads.
Bar = 50 nm. (B) Comparison of the protein profile of EcN and ECOR12 OMVs. Isolated vesicles (10 µg) were separated in a 10%-SDS-PAGE gel and stained with
Sypro R© Ruby. Molecular size markers are indicated. (C) Western blot analysis of LPS in OMVs (0.1 µg protein) or in bacterial lysates (10 µg protein) obtained from
the indicated strains.
We took advantage of the properties of rhodamine isothiocyanate
B-R18 fluorescent dye, whose fluorescence is quenched when
intercalated into bilayer membranes at a high concentration.
However, this dye fluoresces when diluted upon membrane
fusion and internalization. Rhodamine B-R18-labeled OMVs
applied to the apical side of differentiated Caco-2 cells produced
a time-dependent increase in fluorescence. In contrast, no
changes in fluorescence emission were observed in non-treated
cells or samples containing only labeled-OMVs (Figure 4A).
These results are compatible with OMVs uptake by intestinal
epithelial cells. Internalization of OMVs by Caco-2 cells was
assessed by confocal fluorescence microscopy at 1 h incubation
with rhodamine B-R18-labeled OMVs. Immunostaining of the
peripherally associated membrane protein ZO-1 was performed
as an epithelial cell membrane marker. Results presented in
Figure 4B confirmed the presence of EcN and ECOR12 OMVs
in the cytoplasm of Caco-2 cells. Therefore, internalized OMVs
can mediate microbiota immunomodulatory effects in the intact
intestinal mucosa.
OMVs from EcN and ECOR12 Modulate
the Expression of Immuno-modulatory
and Defense Mediators in Ex Vivo Colon
Explants
In this study, the colon organ culture system was used as a closer
model to the in vivo conditions. Gene expression levels of the
selected mediators were analyzed by RT-qPCR (Figure 5A). The
expression profile of the cytokines IL-10, MIP1α, TNF-α, IL-6,
and IL-8 correlated well with the data obtained in the co-culture
system. The corresponding genes were upregulated in colonic
explants incubated with OMVs, but not in those incubated with
bacterial lysates. After 5 h stimulation, statistically significant
increases in the cytokine secreted levels were only observed for
IL-6 and IL-8 (Figure 5B).
In this model, we also examined the expression of other
genes related with host immunomodulatory or defense responses,
including IL-12, TGF-β, IL-22, hBD-2, hBD-1, and MUC1.
OMVs from either EcN or ECOR12 activated transcription of
both IL-22 and the antimicrobial peptide hBD-2, while bacterial
lysates failed to do so (Figure 5A). In contrast, a different
expression profile was seen for the other mediators. Expression
of both the proinflammatory cytokine IL-12 and TGF-β was
downregulated either by OMVs or bacterial lysates. Expression
of MUC1 was also significantly reduced (by nearly 40%) upon
treatment with all the bacterial samples (Figure 5A). Gene
encoding the antimicrobial peptide hBD-1 was not differentially
expressed in any of the conditions tested (not shown).
Although, samples from both EcN and ECOR12 strains
promoted the same expression profile, colonic explants
stimulated with OMVs of the probiotic strain EcN showed a
tendency toward better anti-inflammatory balance. The values
of IL-10/IL-12 and IL-10/TNF-α mRNA ratios were higher in
EcN-treated explants than in ECOR12-treated explants. These
values were 2.50 ± 0.28 versus 1.86 ± 0.20 for IL-10/IL-12 and
1.08± 0.18 versus 0.80± 0.12 for IL-10/TNF-α.
DISCUSSION
In the gut, communication between microbiota and intestinal
mucosa cells has to be established by soluble mediators that can
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FIGURE 2 | Expression analyses of secreted cytokines and chemokines in PBMCs stimulated with OMVs or bacterial lysates. PBMCs were challenged
by addition of OMVs or bacterial lysates from EcN or ECOR12 strains. (A) Cytokine concentration in culture supernatants after 24 h stimulation. Data are expressed
as mean ± SEM. (B) Relative gene expression levels in cells after 5 h stimulation. Data are presented as fold-change compared to untreated control cells. Statistical
differences were assessed by one-way ANOVA followed by Tukey’s test. ∗p ≤ 0.05, versus control cells; #p ≤ 0.05, between cells treated with OMVs from EcN or
ECOR12.
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FIGURE 3 | Expression analysis of secreted cytokines and chemokines in Caco2/PBMCs co-cultures apical stimulation. The apical surface of Caco-2
monolayers was challenged by addition of OMVs or bacterial lysates from EcN or ECOR12 strains. (A) Cytokine concentration in culture supernatants after 24 h
stimulation. Data are expressed as mean ± SEM. Relative gene expression levels in Caco-2 cells (B) and in PBMCs (C) after 5 h stimulation with OMVs. Data are
presented as fold-change compared to untreated control cells. Statistical differences were assessed by the t-test or by the non-parametric Mann–Whitney U-test.
∗p ≤ 0.05, versus control cells; #p ≤ 0.05, between cells treated with OMVs from EcN or ECOR12.
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FIGURE 4 | Outer membrane vesicles uptake by differentiated Caco-2 cells. (A) Rhodamine B-R18-labeled OMVs from EcN or ECOR12 were applied to the
apical side of polarized Caco-2 cells and fluorescence was measured over time (squares). OMVs (triangles) and cells (circles) alone were used as negative controls
for background fluorescence. Statistical differences versus the for background fluorescence emitted by OMVs alone were assessed by one-way ANOVA followed by
Tukey’s test (∗p < 0.05). (B) Visualization of internalized OMVs by fluorescence microscopy. Caco-2 cells were incubated with rhodamine B-R18 labeled OMVs for
1 h at 37◦C. The cell membrane was visualized by immunostaining with antibodies against the zonula occludens ZO-1 protein followed by Alexa Fluor
488-conjugated secondary antibody (green). Nuclei were stained with DAPI (blue). Internalized rhodamine-R18 labeled OMVs are visualized in red. Bar: 20 µm.
diffuse through the mucin layer. Among the bacterial secreted
factors, membrane vesicles have a key role in bacteria-host
communication, allowing the delivery of effector molecules upon
interaction and internalization into the host cells. Many studies
performed in the last decade with pathogens evidenced the role
of bacterial membrane vesicles as an important mechanism to
deliver virulence and immunomodulatory factors to mammalian
target cells. However, reports on microbiota vesicles are still
scarce.
We focused our study to assess whether OMVs released
by probiotic and commensal E. coli strains mediate immune
modulation in cellular models that mimic damaged or intact
intestinal epithelial barrier. To compare the OMVs activity
with that of other bacterial fractions, parallel stimulations were
performed with bacterial lysates. We analyzed expression of
the chemokine MIP1α, the anti-inflammatory cytokine IL-10,
and the pro-inflammatory cytokines IL-6, IL-8, and TNF-α.
Our results show that direct stimulation with both EcN and
ECOR12 OMVs triggered upregulation of all these mediators in
PBMCs. In these cells, the genes regulated by EcN lysates had
been identified through microarray analysis (Güttsches et al.,
2012).The study showed that upregulation of IL-6, IL-8, and
TNF-α by the probiotic strain EcN is mediated either by purified
LPS or lysates, whereas upregulation of IL-10 is mainly activated
by components of the EcN lysate that are not yet identified
(Güttsches et al., 2012). Accordingly, the presence of LPS in
E. coli OMVs may explain the activation of the expression of
IL-6, IL-8, and TNF-α, but upregulation of IL-10 by OMVs
may be attributed to another vesicle factor. In this context, it
should be stressed that EcN OMVs contain some proteins known
to modulate the host immune response, such as the flagellar
components FlgE and FlgK, and the cytoplasmic moonlighting
proteins glyceraldehyde-3-phosphate dehydrogenase and enolase
(Aguilera et al., 2014). These moonlighting proteins can switch
between different functions, depending on the cell location.
Besides their basic metabolic function, when secreted, these
proteins fulfill functions that enable bacteria to colonize and
modulate the host immune response. As presented above,
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FIGURE 5 | Expression levels of the indicated immunomodulatory and defense mediators in human colonic explants. Colonic tissues were challenged for
5 h with OMVs or bacterial lysates from EcN or ECOR12 strains. (A) Relative mRNA levels of the indicated mediators. Data are presented as fold-change compared
to untreated colon fragments. (B) IL-8 and IL-6 protein levels in culture supernatants. Data are presented as mean ± SEM. Statistical differences were assessed by
the t-test. ∗p ≤ 0.05, versus control.
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cytokine secretion levels were lower in PBMCs exposed to OMVs
than in cells exposed to bacterial lysates. The greatest difference
was observed for IL-10. For this anti-inflammatory cytokine,
the secretion levels were more than 10-fold higher in cells
challenged with bacterial lysates, whereas the relative mRNA
levels were similar for both OMV and lysate-stimulated cells.
According to the molecular composition, we could speculate
that bacterial lysates and OMVs activate different signaling
pathways or post-transcriptional regulatory mechanisms that
would account for the different cytokine secreted levels after 24 h
incubation.
The profile of cytokine production by PBMCs incubated
with microbiota lysates was clearly different from the profile
of cytokine secretion in the co-culture model, in which the
epithelial barrier formed by differentiated Caco-2 cells prevent
direct access of the effector molecules to underlying PBMCs.
In this model, secretion of the analyzed cytokines did not
increase over the control levels when the co-culture was apically
stimulated with bacterial lysates. Thus, intestinal epithelial cells
were poorly responsive to lysate components, which are mainly
enriched with cytoplasmic proteins and factors. In contrast,
OMVs elicited an immune response in the epithelial cell
monolayer as shown by the increased gene expression levels of
all the cytokines and chemokines analyzed. This is compatible
with the presence in E. coli OMVs of PPR-ligands, such as
LPS (TLR-4 ligand) or peptidoglycan (NOD-1/NOD-2 ligand)
that can trigger NF-kappa B activation. Here, we have shown
that microbiota E. coli OMVs are internalized in differentiated
Caco-2 cells. Therefore, vesicle uptake can assist the delivery
of specific bacterial ligands to cytosolic NOD-like receptors. In
this co-culture model, activation of the underlying PBMCs upon
apical stimulation by microbiota OMVs was assessed by RT-
qPCR. Although, the relative gene expression values were not
statistically significant after 5 h incubation, the mRNA levels were
manifestly higher in co-cultures challenged with OMVs than
in non-treated cultures. Upregulation and increased secretion
of IL-10, TNF-α, and IL-6 was also described in a co-culture
model of intestinal epithelial cells and dendritic cells after apical
stimulation with EcN bacterial cells (Zoumpopoulou et al.,
2009). Our results prove that PBMCs are stimulated by soluble
factors released from epithelial cells upon exposure to OMVs,
and show for the first time the ability of microbiota vesicles
to mediate signaling events through the intestinal epithelial
barrier.
The role of commensal and probiotic E. coli OMVs as
modulators of the intestinal homeostasis and immunity was
corroborated in the ex vivo model of colon organ culture, which
is closer to the in vivo conditions. As in the co-culture model,
upregulation of MIP1α, IL-10, TNF-α, IL-6, and IL-8 in colonic
mucosa explants was only observed in samples exposed to OMVs.
These vesicles also promoted upregulation of the antimicrobial
peptide hBD-2. Epithelial hBD-2 plays an important role in
intestinal barrier function and many probiotics can induce its
secretion (Wehkamp et al., 2004; Möndel et al., 2009). Induction
of the expression of hBD-2 by EcN depends on flagella synthesis,
as EcN mutants with deletions in genes fliC or flgE fail to induce
this antimicrobial peptide (Schlee et al., 2007). Interestingly,
not all E. coli strains activate hBD-2 expression (Wehkamp
et al., 2004; Möndel et al., 2009). Our results show that OMVs
from both EcN and ECOR12 promote hBD-2 upregulation, with
higher relative expression levels in colonic fragments challenged
with the probiotic OMVs. Induction may be mediated by flagella-
associated proteins present in EcN OMVs, such as FliC or
FlgE (Aguilera et al., 2014). These results provide evidence
that OMVs released by commensal bacteria may also have
positive impact on inducible antimicrobial defense mechanisms.
In contrast, OMVs from these E. coli strains do not significantly
modify expression of hBD-1. This antimicrobial peptide is
constitutively expressed at high levels by colonic epithelial cells,
and functions as a component of the host innate defenses at
the mucosal surface. Our results are in accordance with the
expression pattern reported for this β-defensin. In contrast
to hBD-2, expression of hBD-1 is not inducible by bacterial
components or inflammatory stimuli. However, certain enteric
pathogens promote hBD-1 downregulation as a mechanism to
overcome natural host defenses (reviewed by Cobo and Chadee,
2013).
Another cytokine upregulated in colonic explants by EcN
and ECOR12 OMVs is IL-22. This cytokine is mainly expressed
by immune cells and displays both pro-inflammatory and anti-
inflammatory functions, depending on the tissue and the stimuli
that direct its secretion. The pro-inflammatory properties are
linked to its production by activated T helper 17 (Th17) cells.
The IL-22 targets are typically non-hematopoietic cells, such
as epithelial cells. In the intestine, the innate lymphoid cells
resident in the lamina propria are a main source of IL-22. This
population of cells is essential for the integration of microbiota-
derived signals and the control of the adaptive immune response.
IL-22 released by gut innate lymphoid cells helps to maintain
the integrity of the epithelial barrier by inducing the expression
of β-defensins and the production of mucin by globet cells
(Nikoopour et al., 2015). Therefore, IL-22 has a relevant role
in host-microbiota homeostasis. Expression of this cytokine
by innate lymphoid cells and T cells is activated by certain
microbiota groups known to protect against food allergen
sensitization, such as Clostridia. As a result, increased IL-22
levels reinforce the intestinal epithelial barrier, and therefore
limit the access of allergens to the systemic circulation (Stefka
et al., 2014). Upregulation of IL-22 by OMVs from EcN and
ECOR12 strongly suggest that certain commensal E. coli strains
can confer intestinal barrier protection, and prevent aberrant
responses to food components. In addition, this finding supports
the role of microbiota vesicles as a mechanism to deliver
regulatory signals to the immune cells resident in the intestinal
mucosa.
The expression of genes encoding IL-12, TGF-β and MUC1
was reduced in colonic explants challenged with bacterial
samples. Microbiota OMVs and bacterial lysates promoted
significant downregulation of TGF-β and MUC1. Relative
expression levels were reduced by 25 and 40%, respectively.
Expression of the pro-inflammatory cytokine IL-12 was also
downregulated, although to a lesser extent.
TGF-β is a pleiotropic cytokine with potent regulatory
and inflammatory activities. Its effects depend on cellular and
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environmental factors. This mediator promotes differentiation
of induced Treg cells, which secrete anti-inflammatory cytokines
such as IL-10, and help to control inflammation. However, in
the presence of IL-6, TGF-β can trigger differentiation of Th17
cells through induction of the transcriptional factor Runx1,
promoting further inflammation (Sanjabi et al., 2009; Liu et al.,
2015). Th17 cells are especially abundant in the intestinal
mucosa surfaces, where, in cooperation with Treg cells, they
contribute to preserving intestinal homeostasis. Alteration in
the Th17 (pro-inflammatory)/Treg (anti-inflammatory) balance
toward excessive production of Th17 cells leads to the
pathogenesis of inflammatory bowel diseases (Llopis et al.,
2009). Several probiotics favor the Treg response leading to
the induction and secretion of anti-inflammatory cytokines
such as IL-10 and TGF-β. Our results show that EcN and
ECOR12 trigger downregulation of TGF-β expression. As
the pro-inflammatory effects of TGF-β are related with the
differentiation of Th17 cells, the reduction in TGF-β levels
promoted by these microbiota strains may contribute to restoring
the Th17/Treg balance under inflammatory conditions. This
mechanism may explain the effectiveness of the probiotic
EcN in the remission of ulcerative colitis (Kruis et al.,
2004).
MUC1 is a membrane-anchored mucin, located in the
apical surface of mucosal epithelial cells. Production of this
mucin by colonic epithelial cells is stimulated by IL-17 released
by Th17 cells, and MUC1 in turn negatively regulates the
Th17 cell responses in inflamed gut (Nishida et al., 2012). In
fact the MUC1 gene has been linked with susceptibility to
inflammatory bowel disease (Apostolopoulos et al., 2015). This
mucin has been associated with barrier functions. However,
different models have shown contradictory results. Deficiency
of MUC1 results in increased colonic permeability and IL-17
responses in knockout mice lacking the T cell receptor (Nishida
et al., 2012), whereas knockdown of MUC1 in corneal epithelial
cells did not modify the barrier function (Gipson et al., 2014).
In vitro studies performed in the colon adenocarcinoma cell
line LS174T showed upregulation of MUC1 by probiotic strains,
including EcN. However, this effect was not observed in an
in vivo murine model (Becker et al., 2013). Similarly, analysis of
MUC1 expression in mice colonized with EcN during the first
week of life did not reveal any increase in the MUC1 mRNA
levels when compared to the control group (Bergström et al.,
2012).
Interestingly, both MUC1 and TGF-β are overexpressed in
several cancer types (Khanh do et al., 2013; Apostolopoulos
et al., 2015). As EcN and commensal E. coli strains promote
downregulation of both mediators in intestinal mucosa explants,
we may hypothesize that these microbiota strains could help to
reduce cancer progression or to increase treatment effectiveness
(Viaud et al., 2015). This is especially interesting in the context
of immunotherapy strategies in which the individual response
to these therapies has been shown to be dependent on gut
microbiota (Sivan et al., 2015; Vétizou et al., 2015).
CONCLUSION
Recent knowledge supports that microbiota is a source of
regulatory signals that influence the development and maturation
of the digestive and immune systems. Nowadays, potential
clinical applications of gut microbes are foreseen. However,
translation of microbiota-based drugs to human health care
requires deep knowledge of the molecular mechanisms involved
in microbiota-host interaction (Jia et al., 2008; Shanahan,
2011). Our study proves the ability of microbiota vesicles to
mediate signaling events to the immune system through the
intestinal epithelial barrier. Therefore, OMVs are an effective
strategy used by beneficial bacteria of the human microbiota
to communicate with intestinal mucosa cells, promoting the
delivery of mediators that trigger host immune and defense
responses. The in vivo beneficial effects of the probiotic EcN
on gut homeostasis, especially modulation of the immune
response and barrier function, can be mediated by released
OMVs.
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